EDGAR Filing Documents for 0001104659-23-093484

Form 8-K - Current report:

SEC Accession No. 0001104659-23-093484

Filing Date

2023-08-18

Accepted

2023-08-18 16:06:07

Documents

Period of Report

2023-08-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2324125d1_8k.htm iXBRL	8-K	38969
2	EXHIBIT 4.1	tm2324125d1_ex4-1.htm	EX-4.1	94466
3	EXHIBIT 4.2	tm2324125d1_ex4-2.htm	EX-4.2	102151
4	EXHIBIT 4.3	tm2324125d1_ex4-3.htm	EX-4.3	100597
5	EXHIBIT 4.4	tm2324125d1_ex4-4.htm	EX-4.4	94312
6	EXHIBIT 5.1	tm2324125d1_ex5-1.htm	EX-5.1	27557
7	EXHIBIT 10.1	tm2324125d1_ex10-1.htm	EX-10.1	259251
8	EXHIBIT 99.1	tm2324125d1_ex99-1.htm	EX-99.1	14617
12	GRAPHIC	tm2324125d1_ex5-1img001.jpg	GRAPHIC	2794
	Complete submission text file	0001104659-23-093484.txt		1085515

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	rvlp-20230815.xsd	EX-101.SCH	3015
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rvlp-20230815_lab.xml	EX-101.LAB	34240
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rvlp-20230815_pre.xml	EX-101.PRE	22359
14	EXTRACTED XBRL INSTANCE DOCUMENT	tm2324125d1_8k_htm.xml	XML	3308

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807

Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300

RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 231185923
SIC: 2834 Pharmaceutical Preparations